NCT02379702

Brief Summary

Following the first study conducted to investigate the prevalence of metabolic syndrome and its components in Turkey, it was aimed to demonstrate the change in general health condition of available patients after the period of time lapsed. This study will provide important information on the social and economic dimensions of metabolic syndrome and will contribute to development of preventive programs.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,659

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jun 2014

Shorter than P25 for all trials

Geographic Reach
1 country

6 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2014

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

October 17, 2014

Completed
15 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2014

Completed
4 months until next milestone

First Posted

Study publicly available on registry

March 5, 2015

Completed
Last Updated

March 5, 2015

Status Verified

March 1, 2015

Enrollment Period

5 months

First QC Date

October 17, 2014

Last Update Submit

March 2, 2015

Conditions

Metabolic Syndrome

Outcome Measures

Primary Outcomes (1)

  • comorbidities and changes in general health

    10 year

Interventions

Metabolic SyndromeOTHER

This study will provide important information on the social and economic dimensions of metabolic syndrome

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The previous study included 4.264 patients from 47 cities and we are going to try to get in contact all those patients. Data obtained from available patients will be analysed and the change trend will be evaluated

You may qualify if:

  • Volunteers who participated in the METSAR-I study in 2003
  • Patients who accepted to participate will be included the second follow up phase.

You may not qualify if:

  • None

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (6)

Ankara University

Ankara, Turkey (Türkiye)

Location

Gazi University

Ankara, Turkey (Türkiye)

Location

Yuksek Ihtisas Hospital

Ankara, Turkey (Türkiye)

Location

Istanbul Cerrahpasa University

Istanbul, Turkey (Türkiye)

Location

Istanbul Medeniyet University

Istanbul, Turkey (Türkiye)

Location

Prof. Dr. Omer Kozan

Izmir, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Metabolic Syndrome

Interventions

ANAPC16 protein, human

Condition Hierarchy (Ancestors)

Insulin ResistanceHyperinsulinismGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic Diseases

Study Officials

  • Omer Kozan

    Dokuz Eylul University

    STUDY DIRECTOR

Study Design

Study Type
observational
Time Perspective
PROSPECTIVE
Target Duration
10 Years
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 17, 2014

First Posted

March 5, 2015

Study Start

June 1, 2014

Primary Completion

November 1, 2014

Study Completion

November 1, 2014

Last Updated

March 5, 2015

Record last verified: 2015-03

Locations

TU(6)